Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis
Authors:
- 5 December 2014
- journal article
- research article
- Published by Springer Nature in Hepatology International
- Vol. 9 (1) , 120-129
Abstract
Our purpose was to conduct a meta-analysis to compare the effectiveness of vasopressin/terlipressin and somatostatin/octreotide on variceal re-bleeding within and after 5 days of initial control bleeding.Keywords
This publication has 40 references indexed in Scilit:
- Meta‐analysis: vasoactive medications for the management of acute variceal bleedsAlimentary Pharmacology & Therapeutics, 2012
- Management of Varices and Variceal Hemorrhage in CirrhosisNew England Journal of Medicine, 2010
- A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleedingJournal of Hepatology, 2006
- Terlipressin for acute esophageal variceal hemorrhageCochrane Database of Systematic Reviews, 2003
- Somatostatin and analogues in portal hypertensionHepatology, 2002
- Improving prognosis following a first variceal haemorrhage over four decadesGut, 2001
- UK guidelines on the management of variceal haemorrhage in cirrhotic patientsGut, 2000
- Time profile of the haemodynamic effects of terlipressin in portal hypertensionJournal of Hepatology, 1997
- Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosisJournal of Hepatology, 1994
- A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varicesJournal of Gastroenterology and Hepatology, 1990